Lexaria notes FDA approval of Eli Lilly's oral weight-loss drug Foundayo
Go back to Lexaria notes FDA approval of Eli Lilly's oral weight-loss drug Foundayo| (NASDAQ: LEXX) | Delayed: 0.56 -0.01 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.57 | 52 Week High | $ | |||
| Open | $0.55 | 52 Week Low | $ | |||
| Day High | $0.58 | P/E | N/A | |||
| Day Low | $0.54 | EPS | $ | |||
| Volume | 50,748 | |||||

